Cargando…
Personalized medicine for rare neurogenetic disorders: can we make it happen?
Rare neurogenetic disorders are collectively common, affecting 3% of the population, and often manifest with complex multiorgan comorbidity. With advances in genetic, -omics, and computational analysis, more children can be diagnosed and at an earlier age. Innovations in translational research facil...
Autores principales: | van Eeghen, Agnies M., Bruining, Hilgo, Wolf, Nicole I., Bergen, Arthur A., Houtkooper, Riekelt H., van Haelst, Mieke M., van Karnebeek, Clara D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958924/ https://www.ncbi.nlm.nih.gov/pubmed/35332073 http://dx.doi.org/10.1101/mcs.a006200 |
Ejemplares similares
-
Personal experience: Diagnosis and dilemmas - what happens when we diagnose patients with the label ‘schizophrenia’
por: Ellerby, Mark
Publicado: (2014) -
We can make it happen
por: Kallestrup, Per
Publicado: (2017) -
NAD(+) homeostasis in human health and disease
por: Zapata‐Pérez, Rubén, et al.
Publicado: (2021) -
Antibiotic use and abuse: A threat to mitochondria and chloroplasts with impact on research, health, and environment
por: Wang, Xu, et al.
Publicado: (2015) -
A Scoping Review of Inborn Errors of Metabolism Causing Progressive Intellectual and Neurologic Deterioration (PIND)
por: Warmerdam, Hilde A. G., et al.
Publicado: (2020)